Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Venous Thromboembolism 8Neoplasms 4Thrombosis 3Pulmonary Embolism 3Venous Thrombosis 2Multiple Myeloma 2Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Upper Extremity Deep Vein Thrombosis 1Thromboembolism 1Thrombocytopenia 1Ovarian Neoplasms 1Lymphoma 1Leukemia 1Hematologic Neoplasms 1Head and Neck Neoplasms 1Glioma 1Glioblastoma 1Fibrosis 1Endometrial Neoplasms 1Catheter-Related Infections 1Carcinoma, Hepatocellular 1Astrocytoma 1

Interventions

Liver Transplantation 2Blood Specimen Collection 2esmolol 1atezolizumab 1apixaban 1User-Centered Design 1Tocopherols 1Standard of Care 1Sampling Studies 1Pravastatin 1Pharmaceutical Preparations 1Pentoxifylline 1Neuropsychological Tests 1Memantine 1Losartan 1Ketoprofen 1Enoxaparin 1Endoscopy, Digestive System 1Diagnostic Imaging 1Bevacizumab 12-chloro-N(6)-(3-iodobenzyl)adenosine-5'-N-methyluronamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Fibrosis × apixaban × Clear all
NCT07132515 2025-08-20

Efficacy & Safety of Anticoagulants in Cirrhosis ± HCC

Mansoura University

Phase 4 Recruiting
100 enrolled
Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡